Added to YB: 2025-09-22
Pitch date: 2025-09-18
CLSD [bullish]
Clearside Biomedical, Inc.
-77.66%
current return
Author Info
BiotechBonanza shares takes on biotech with a heavy focus on special situations. Sign up for the newsletter.
Company Info
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.
Market Cap
$18.9M
Pitch Price
$3.85
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.11
P/E
-0.66
EV/Sales
15.78
Sector
Pharmaceuticals
Category
special_situation
CLSD: Large pot of gold behind multiple walls of defense
CLSD: Exploring strategic alternatives after firing all staff. Owns royalty rights to FDA-approved XIPERE (Bausch) & ABBV/RGNX gene therapy partnership. ABBV upgraded opportunity from 'small' to 'highly transformative.' BUT: sold first $106M proceeds to HCR, ~$3-10M net debt, no institutional holders, patents expire risk. Paths to multibagger or zero.
Read full article (12 min)